Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 613

1.

Unique clinico-biological, genetic and prognostic features of adult early T cell precursor acute lymphoblastic leukemia.

Genescà E, Morgades M, Montesinos P, Barba P, Gil C, Guàrdia R, Moreno MJ, Martínez-Carballeira D, García-Cadenas I, Vives S, Ribera J, González-Campos J, González-Gil C, Zamora L, Ramírez JL, Díaz-Beya M, Mercadal S, Artola MT, Cladera A, Tormo M, Bermúdez A, Vall-Llovera F, Martínez P, Amigo ML, Monsalvo S, Novo A, Cervera M, García-Guiñon A, Juncà J, Ciudad J, Orfao A, Ribera JM.

Haematologica. 2019 Sep 19. pii: haematol.2019.225078. doi: 10.3324/haematol.2019.225078. [Epub ahead of print]

2.

Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.

Carvajal S, Perramón M, Oró D, Casals E, Fernández-Varo G, Casals G, Parra M, González de la Presa B, Ribera J, Pastor Ó, Morales-Ruíz M, Puntes V, Jiménez W.

Sci Rep. 2019 Sep 6;9(1):12848. doi: 10.1038/s41598-019-49262-2.

3.

M7FLIPI AND TARGETED SEQUENCING IN HIGH-RISK FOLLICULAR LYMPHOMA.

Sorigue M, Oliveira A, Mercadal S, Tapia G, Climent F, Perez-Roca L, Lorences I, Domingo-Domenech E, Cabezon M, Navarro JT, Gonzalez-Barca E, Zamora L, Ribera JM, Sureda A, Armengol MP, Sancho JM.

Hematol Oncol. 2019 Sep 2. doi: 10.1002/hon.2674. [Epub ahead of print]

PMID:
31475375
4.

Using the CODIT model to explain secondary metabolites of the xylem in defence systems of temperate trees to decay fungi.

Morris H, Hietala AM, Jansen S, Ribera J, Rosner S, Salmeia KA, Schwarze FWMR.

Ann Bot. 2019 Aug 17. pii: mcz138. doi: 10.1093/aob/mcz138. [Epub ahead of print]

PMID:
31420666
5.

Blastic plasmacytoid dendritic cell neoplasm. A study of three cases.

Sitges M, Vives S, Ribera JM.

Med Clin (Barc). 2019 Jul 23. pii: S0025-7753(19)30405-1. doi: 10.1016/j.medcli.2019.04.029. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31350059
6.

Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Ribera J, Zamora L, Morgades M, Vives S, Granada I, Montesinos P, Gómez-Seguí I, Mercadal S, Guàrdia R, Nomdedeu J, Pratcorona M, Tormo M, Martínez-Lopez J, Hernández-Rivas JM, Ciudad J, Orfao A, González-Campos J, Barba P, Escoda L, Esteve J, Genescà E, Solé F, Feliu E, Ribera JM; Spanish PETHEMA Group; Spanish Society of Hematology.

Genes Chromosomes Cancer. 2019 Nov;58(11):815-819. doi: 10.1002/gcc.22788. Epub 2019 Aug 7.

PMID:
31340073
7.

Treatment adapted to pregnancy in a patient with Burkitt lymphoma.

Comes M, Batlle M, Ribera JM.

Med Clin (Barc). 2019 Jul 20. pii: S0025-7753(19)30417-8. doi: 10.1016/j.medcli.2019.04.038. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31337491
8.

Sprouty1 Controls Genitourinary Development via its N-Terminal Tyrosine.

Vaquero M, Cuesta S, Anerillas C, Altés G, Ribera J, Basson MA, Licht JD, Egea J, Encinas M.

J Am Soc Nephrol. 2019 Aug;30(8):1398-1411. doi: 10.1681/ASN.2018111085. Epub 2019 Jul 12.

PMID:
31300484
9.

Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?

Gassiot S, González Y, Morgades M, Motlló C, Clapés V, Maluquer C, Ibarra G, Abril L, Ribera JM, Oriol A.

Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):585-592.e1. doi: 10.1016/j.clml.2019.05.020. Epub 2019 Jun 5.

PMID:
31255588
10.

Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats.

Ribera J, Rodríguez-Vita J, Cordoba B, Portolés I, Casals G, Casals E, Jiménez W, Puntes V, Morales-Ruiz M.

PLoS One. 2019 Jun 24;14(6):e0218716. doi: 10.1371/journal.pone.0218716. eCollection 2019.

11.

Natural history and cell of origin of TC F3-ZN F384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL.

Bueno C, Tejedor JR, Bashford-Rogers R, González-Silva L, Valdés-Mas R, Agraz-Doblás A, Díaz de la Guardia R, Ribera J, Zamora L, Bilhou-Nabera C, Abermil N, Guermouche H, Gouache E, Leverger G, Fraga MF, Fernández AF, Ballerini P, Varela I, Menendez P.

Blood. 2019 Sep 12;134(11):900-905. doi: 10.1182/blood.2019000893. Epub 2019 Jun 20. No abstract available.

PMID:
31221673
12.

Adherence to reporting guidelines increases the number of citations: the argument for including a methodologist in the editorial process and peer-review.

Vilaró M, Cortés J, Selva-O'Callaghan A, Urrutia A, Ribera JM, Cardellach F, Basagaña X, Elmore M, Vilardell M, Altman D, González JA, Cobo E.

BMC Med Res Methodol. 2019 May 31;19(1):112. doi: 10.1186/s12874-019-0746-4.

13.

Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.

López-Corral L, Caballero-Velázquez T, López-Godino O, Rosiñol L, Pérez-Vicente S, Fernandez-Avilés F, Krsnik I, Morillo D, Heras I, Morgades M, Rifon JJ, Sampol A, Iniesta F, Ocio EM, Martin J, Rovira M, Cabero M, Castilla-Llorente C, Ribera JM, Torres-Juan M, Moraleda JM, Martinez C, Vázquez A, Gutierrez G, Caballero D, San Miguel JF, Mateos MV, Pérez-Simón JA.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1703-1712. doi: 10.1016/j.bbmt.2019.04.026. Epub 2019 May 3.

PMID:
31054983
14.

Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.

Ribera JM, García O, Moreno MJ, Barba P, García-Cadenas I, Mercadal S, Montesinos P, Barrios M, González-Campos J, Martínez-Carballeira D, Gil C, Ribera J, Vives S, Novo A, Cervera M, Serrano J, Lavilla E, Abella E, Tormo M, Amigo ML, Artola MT, Genescà E, Bravo P, García-Belmonte D, García-Guiñón A, Hernández-Rivas JM, Feliu E; PETHEMA Group of the Spanish Society of Hematology.

Cancer. 2019 Aug 15;125(16):2810-2817. doi: 10.1002/cncr.32156. Epub 2019 Apr 23.

PMID:
31012967
15.

Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Stein AS, Kantarjian H, Gökbuget N, Bargou R, Litzow MR, Rambaldi A, Ribera JM, Zhang A, Zimmerman Z, Zugmaier G, Topp MS.

Biol Blood Marrow Transplant. 2019 Aug;25(8):1498-1504. doi: 10.1016/j.bbmt.2019.04.010. Epub 2019 Apr 17.

16.

Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma.

Sorigue M, Bishton M, Domingo-Domenech E, McMillan A, Prusila R, García O, Kuusisto M, Condom M, Tapia G, Ribera JM, Kuittinen O, Fox CP, Sancho JM.

Leuk Lymphoma. 2019 Oct;60(10):2524-2531. doi: 10.1080/10428194.2019.1594212. Epub 2019 Apr 3.

PMID:
30942640
17.

The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients.

Ribera J, Granada I, Morgades M, Vives S, Genescà E, González C, Nomdedeu J, Escoda L, Montesinos P, Mercadal S, Coll R, González-Campos J, Abella E, Barba P, Bermúdez A, Gil C, Tormo M, Pedreño M, Martínez-Carballeira D, Hernández-Rivas JM, Orfao A, Martínez-López J, Esteve J, Bravo P, Garcia-Guiñon A, Debén G, Moraleda JM, Queizán JA, Ortín X, Moreno MJ, Feliu E, Solé F, Ribera JM; PETHEMA Group, Spanish Society of Haematology.

Br J Haematol. 2019 Jul;186(2):263-268. doi: 10.1111/bjh.15887. Epub 2019 Mar 27.

PMID:
30916384
18.

Efficacy of mefloquine and mirtazapine on progressive multifocal leukoencephalopathy in a patient with peripheral T-cell lymphoma.

Peña M, Presas-Rodríguez S, Ribera JM.

Med Clin (Barc). 2019 Feb 22. pii: S0025-7753(19)30050-8. doi: 10.1016/j.medcli.2019.01.004. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
30803799
19.

Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia.

Jaiteh F, Masunaga Y, Okebe J, D'Alessandro U, Balen J, Bradley J, Gryseels C, Ribera JM, Grietens KP.

Malar J. 2019 Feb 18;18(1):39. doi: 10.1186/s12936-019-2672-7.

20.

Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia.

Gökbuget N, Dombret H, Giebel S, Bruggemann M, Doubek M, Foà R, Hoelzer D, Kim C, Martinelli G, Parovichnikova E, Rambaldi A, Ribera JM, Schoonen M, Stieglmaier JM, Zugmaier G, Bassan R.

Hematology. 2019 Dec;24(1):337-348. doi: 10.1080/16078454.2019.1567654.

21.

Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Valiollahi E, Ribera JM, Genescà E, Behravan J.

Mol Biol Rep. 2019 Feb;46(1):1295-1306. doi: 10.1007/s11033-019-04600-5. Epub 2019 Feb 2.

PMID:
30712246
22.

Scalable Biosynthesis of Melanin by the Basidiomycete Armillaria cepistipes.

Ribera J, Panzarasa G, Stobbe A, Osypova A, Rupper P, Klose D, Schwarze FWMR.

J Agric Food Chem. 2019 Jan 9;67(1):132-139. doi: 10.1021/acs.jafc.8b05071. Epub 2018 Dec 19.

PMID:
30541276
23.

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.

Labrador J, Luño E, Vellenga E, Brunet S, González-Campos J, Chillón MC, Holowiecka A, Esteve J, Bergua J, González-Sanmiguel JD, Gil C, Tormo M, Salamero O, Manso F, Fernández I, de laSerna J, Moreno MJ, Pérez-Encinas M, Krsnik I, Ribera JM, Cervera J, Calasanz MJ, Boluda B, Sobas M, Lowenberg B, Sanz MA, Montesinos P.

Leuk Lymphoma. 2019 May;60(5):1146-1155. doi: 10.1080/10428194.2018.1522438. Epub 2018 Dec 11.

PMID:
30526152
24.

A step ahead in Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Ribera JM.

Lancet Haematol. 2018 Dec;5(12):e602-e603. doi: 10.1016/S2352-3026(18)30195-9. No abstract available.

PMID:
30501863
25.

Interregional Newborn Hearing Screening via Telehealth in Ghana.

Ameyaw GA, Ribera J, Anim-Sampong S.

J Am Acad Audiol. 2019 Mar;30(3):178-186. doi: 10.3766/jaaa.17059. Epub 2018 Feb 7.

PMID:
30461394
26.

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Giebel S, Marks DI, Boissel N, Baron F, Chiaretti S, Ciceri F, Cornelissen JJ, Doubek M, Esteve J, Fielding A, Foa R, Gorin NC, Gökbuget N, Hallböök H, Hoelzer D, Paravichnikova E, Ribera JM, Savani B, Rijneveld AW, Schmid C, Wartiovaara-Kautto U, Mohty M, Nagler A, Dombret H.

Bone Marrow Transplant. 2019 Jun;54(6):798-809. doi: 10.1038/s41409-018-0373-4. Epub 2018 Nov 1. Review.

27.

An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens.

Sobas M, Montesinos P, Boluda B, Bernal T, Vellenga E, Nomdedeu J, González-Campos J, Chillón M, Holowiecka A, Esteve J, Bergua J, González-Sanmiguel JD, Gil-Cortes C, Tormo M, Salamero O, Manso F, Fernández I, de la Serna J, Moreno MJ, Pérez-Encinas M, Krsnik I, Ribera JM, Escoda L, Lowenberg B, Sanz MA; PETHEMA, HOVON, PALG, and GATLA cooperative groups.

Leuk Lymphoma. 2019 Apr;60(4):1030-1035. doi: 10.1080/10428194.2018.1516875. Epub 2018 Oct 15.

PMID:
30322324
28.

Overall survival in patients with relapsed/refractory high grade B-cell lymphomas treated with gemcitabine, oxaliplatin with or without rituximab.

Franch-Sarto M, Sorigue M, López L, Moreno M, Ribera JM, Sancho JM.

Leuk Lymphoma. 2018 Oct 15:1-3. doi: 10.1080/10428194.2018.1519813. [Epub ahead of print] No abstract available.

PMID:
30322316
29.

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma.

Baptista MJ, Tapia G, Morgades M, Muncunill J, Muñoz-Marmol AM, Montoto S, Gribben JG, Calaminici M, Martinez A, Gonzalez-Farre B, Dlouhy I, González-Barca E, Terol MJ, Miralles P, Alcoceba M, Vall-Llovera F, Briones J, Abrisqueta P, Abella E, Provencio M, García-Ballesteros C, Moraleda JM, Sancho JM, Ribera JM, Mate JL, Navarro JT.

Leuk Lymphoma. 2019 Apr;60(4):1087-1091. doi: 10.1080/10428194.2018.1512711. Epub 2018 Oct 15. No abstract available.

PMID:
30322315
30.

Therapy-related acute lymphoblastic leukemia.

Ribera JM.

Haematologica. 2018 Oct;103(10):1581-1583. doi: 10.3324/haematol.2018.200311. No abstract available.

31.

Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.

Barba P, Morgades M, Montesinos P, Gil C, Fox ML, Ciudad J, Moreno MJ, González-Campos J, Genescà E, Martínez-Carballeira D, Martino R, Vives S, Guardia R, Mercadal S, Artola MT, Cladera A, Tormo M, Esteve J, Bergua J, Vall-Llovera F, Ribera J, Martínez-Sanchez P, Amigo ML, Bermúdez A, Calbacho M, Hernández-Rivas JM, Feliu E, Orfao A, Ribera JM.

Eur J Haematol. 2019 Jan;102(1):79-86. doi: 10.1111/ejh.13178. Epub 2018 Nov 22.

PMID:
30267597
32.

Indications and use of, and incidence of major bleeding with, antithrombotic agents in myelodysplastic syndrome.

Sorigue M, Nieto J, Santos-Gomez M, Sarrate E, Jiménez MJ, Morales-Indiano C, Lopez-Viaplana L, Orna E, Navarro JT, Ribera JM, Xicoy B.

Leuk Res. 2018 Oct;73:24-28. doi: 10.1016/j.leukres.2018.08.017. Epub 2018 Aug 31.

PMID:
30193204
33.

Graphene-Dendrimer Nanostars for Targeted Macrophage Overexpression of Metalloproteinase 9 and Hepatic Fibrosis Precision Therapy.

Melgar-Lesmes P, Luquero A, Parra-Robert M, Mora A, Ribera J, Edelman ER, Jiménez W.

Nano Lett. 2018 Sep 12;18(9):5839-5845. doi: 10.1021/acs.nanolett.8b02498. Epub 2018 Aug 16.

34.

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.

Genescà E, Lazarenkov A, Morgades M, Berbis G, Ruíz-Xivillé N, Gómez-Marzo P, Ribera J, Juncà J, González-Pérez A, Mercadal S, Guardia R, Artola MT, Moreno MJ, Martínez-López J, Zamora L, Barba P, Gil C, Tormo M, Cladera A, Novo A, Pratcorona M, Nomdedeu J, González-Campos J, Almeida M, Cervera J, Montesinos P, Batlle M, Vives S, Esteve J, Feliu E, Solé F, Orfao A, Ribera JM.

J Hematol Oncol. 2018 Jul 24;11(1):96. doi: 10.1186/s13045-018-0639-8.

35.

Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas.

Muncunill J, Baptista MJ, Hernandez-Rodríguez Á, Dalmau J, Garcia O, Tapia G, Moreno M, Sancho JM, Martínez-Picado J, Feliu E, Mate JL, Ribera JM, Navarro JT.

Clin Infect Dis. 2019 Feb 15;68(5):834-843. doi: 10.1093/cid/ciy542.

PMID:
29982484
36.

Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia.

Buatois V, Johnson Z, Salgado-Pires S, Papaioannou A, Hatterer E, Chauchet X, Richard F, Barba L, Daubeuf B, Cons L, Broyer L, D'Asaro M, Matthes T, LeGallou S, Fest T, Tarte K, Clarke Hinojosa RK, Genescà Ferrer E, Ribera JM, Dey A, Bailey K, Fielding AK, Eissenberg L, Ritchey J, Rettig M, DiPersio JF, Kosco-Vilbois MH, Masternak K, Fischer N, Shang L, Ferlin WG.

Mol Cancer Ther. 2018 Aug;17(8):1739-1751. doi: 10.1158/1535-7163.MCT-17-1095. Epub 2018 May 9.

37.

Cardiac arrest in a patient diagnosed with acute myeloid leukemia after the first dose of idarubicin.

Peña M, Serra J, Ribera JM.

Med Clin (Barc). 2018 Dec 21;151(12):506-507. doi: 10.1016/j.medcli.2018.03.032. Epub 2018 May 3. English, Spanish. No abstract available.

PMID:
29731139
38.

Graft-versus-host disease after an infection by Rickettsia conorii induced by a tick's bite.

Torrent A, Ferrá C, Ribera JM.

Med Clin (Barc). 2019 Feb 1;152(3):119-120. doi: 10.1016/j.medcli.2018.03.019. Epub 2018 May 3. English, Spanish. No abstract available.

PMID:
29729935
39.

Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma.

Sorigue M, Gual-Capllonch F, Garcia O, Sarrate E, Franch-Sarto M, Ibarra G, Grau J, Orna E, Ribera JM, Sancho JM.

Ann Hematol. 2018 Sep;97(9):1633-1640. doi: 10.1007/s00277-018-3346-1. Epub 2018 May 4.

PMID:
29728734
40.

Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Ribera JM, García O, Gil C, Mercadal S, García-Cadenas I, Montesinos P, Barba P, Vives S, González-Campos J, Tormo M, Esteve J, López A, Moreno MJ, Ribera J, Alonso N, Bermúdez A, Amigo ML, Genescà E, García D, Vall-Llovera F, Bergua JM, Guàrdia R, Monteserín MC, Bernal T, Calbacho M, Martínez MP, Feliu E; PETHEMA Group.

Leuk Res. 2018 May;68:79-84. doi: 10.1016/j.leukres.2018.03.010. Epub 2018 Mar 19.

PMID:
29574396
41.

Reactive community-based self-administered treatment against residual malaria transmission: study protocol for a randomized controlled trial.

Okebe J, Ribera JM, Balen J, Jaiteh F, Masunaga Y, Nwakanma D, Bradley J, Yeung S, Peeters Grietens K, D'Alessandro U.

Trials. 2018 Feb 20;19(1):126. doi: 10.1186/s13063-018-2506-x.

42.

Preparation of a Sepia Melanin and Poly(ethylene-alt-maleic Anhydride) Hybrid Material as an Adsorbent for Water Purification.

Panzarasa G, Osypova A, Consolati G, Quasso F, Soliveri G, Ribera J, Schwarze FWMR.

Nanomaterials (Basel). 2018 Jan 23;8(2). pii: E54. doi: 10.3390/nano8020054.

43.

Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.

Guillem V, Calabuig M, Brunet S, Esteve J, Escoda L, Gallardo D, Ribera JM, Queipo de Llano MP, Arnan M, Pedro C, Amigo ML, Martí-Tutusaus JM, García-Guiñón A, Bargay J, Sampol A, Salamero O, Font L, Talarn C, Hoyos M, Díaz-Beyá M, Garrido A, Navarro B, Nomdédeu J, Sierra J, Tormo M.

Leuk Lymphoma. 2018 Oct;59(10):2383-2393. doi: 10.1080/10428194.2017.1422858. Epub 2018 Jan 18.

PMID:
29345176
44.

Rescue treatment of patients with relapsed acute leukemia after first allogeneic hematopoietic stem cell transplantation.

Torrent A, Ferrá C, Ribera JM.

Med Clin (Barc). 2018 Nov 9;151(9):376-377. doi: 10.1016/j.medcli.2017.11.044. Epub 2017 Dec 31. English, Spanish. No abstract available.

PMID:
29295789
45.

Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.

Rovó A, Kulasekararaj A, Medinger M, Chevallier P, Ribera JM, Peffault de Latour R, Knol C, Iacobelli S, Kanfer E, Bruno B, Maury S, Quarello P, Koh MBC, Schouten H, Blau IW, Tichelli A, Hill A, Risitano A, Passweg J, Marsh J, Dreger P, Dufour C; Severe Aplastic Anaemia Working Party of the EBMT.

Br J Haematol. 2019 Jan;184(2):294-298. doi: 10.1111/bjh.15074. Epub 2017 Dec 19. No abstract available.

PMID:
29265360
46.

Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.

Ribera JM, Morgades M, Montesinos P, Martino R, Barba P, Soria B, Bermúdez A, Moreno MJ, González-Campos J, Vives S, Gil C, Abella E, Guàrdia R, Martínez-Carballeira D, Martínez-Sánchez P, Amigo ML, Mercadal S, Serrano A, López-Martínez A, Vall-Llovera F, Sánchez-Sánchez MJ, Peñarrubia MJ, Calbacho M, Méndez JA, Bergua J, Cladera A, Tormo M, García-Belmonte D, Feliu E, Ciudad J, Orfao A; PETHEMA Group, Spanish Society of Hematology.

Leuk Lymphoma. 2018 Jul;59(7):1634-1643. doi: 10.1080/10428194.2017.1397661. Epub 2017 Nov 22.

PMID:
29165013
47.

Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia.

Ribera JM.

Expert Rev Hematol. 2017 Dec;10(12):1057-1067. doi: 10.1080/17474086.2017.1396890. Epub 2017 Nov 1. Review.

PMID:
29082835
48.

Effects of electrical stimulation in the treatment of osteonecrosis of the femoral head.

Fornell S, Ribera J, Mella M, Carranza A, Serrano-Toledano D, Domecq G.

Hip Int. 2018 Jul;28(4):434-441. doi: 10.5301/hipint.5000581. Epub 2017 Oct 16.

PMID:
29048692
49.

Second neoplasms in adult patients submitted to haematopoietic stem cell transplantation.

Torrent A, Ferrá C, Morgades M, Jiménez MJ, Sancho JM, Vives S, Batlle M, Moreno M, Xicoy B, Oriol A, Ibarra G, Ribera JM.

Med Clin (Barc). 2018 Jun 8;150(11):421-427. doi: 10.1016/j.medcli.2017.07.004. Epub 2017 Sep 2. English, Spanish.

PMID:
28874263
50.

The case for lymphoma-specific survival.

Sorigue M, Sarrate E, Ribera JM, Sancho JM.

Expert Rev Hematol. 2018 Apr;11(4):263-264. doi: 10.1080/17474086.2017.1367659. Epub 2017 Aug 23. No abstract available.

PMID:
28806107

Supplemental Content

Loading ...
Support Center